Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:6/22/2018
Start Date:November 2015
End Date:November 2016

Use our guide to learn which trials are right for you!

To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard
HD end caps compared to the Tego® connector with the Curos® for Tego disinfecting port
protector.

Prospective, cluster-randomized, open-label, post market, comparative effectiveness
evaluation with facilities participating for up to 12 months.

Inclusion Criteria:

- All patients dialyzing with a central venous catheter

Exclusion Criteria:

- Known allergy to chlorhexidine
We found this trial at
1
site
825 South 8th Street
Minneapolis, Minnesota 55404
888-345-2567
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials